ACS Omega · 2022 · 33 citations · 19 references
PharmacyMicrobiologyPharmaceuticsBiomaterialsDrug DeliveryNanoparticle Drug DeliveryBacterial BiofilmsBiofilm FormationLipid-based NanoparticlesNanomaterials For Drug DeliveryNanomedicineNanoparticle DesignAntimicrobial NanomaterialsDrug Delivery NanocarriersHybrid NanoparticlesLipid NanoparticlesNanoparticle-based AntimicrobialsNanoparticlesPoly(lactic-co-glycolic Acid)Poly(lactic-co-glycolic Acid) Nanoparticles
USA300 when compared against Free-Van and Van-PLGANPs. When used to treat USA300 biofilms, Van-LCHNPs eradicated up to 99.99% of the underlying biofilm cells, an effect which was not observed for Free-Van and Van-PLGANPs. Finally, we showed that by possessing a robust DOTAP shell, LCHNPs were able to penetrate deeply into the biofilms.
19
Olivier Habimana, Andrea J.C. Semião, Eoin Casey · Journal of Membrane Science · 2013 · 253 citations · Full text
Yutao Liu, Jie Pan, Si‐Shen Feng · International Journal of Pharmaceutics · 2010 · 168 citations